Western Medicine GMP Certificated Injection, Dxms

• Application: Internal Medicine
• Usage Mode: I.M/I.V
• Suitable for: Elderly, Children, Adult
• State: Liquid
• Shape: Injection
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: Available
• Drug Ad Approval No.: Available
• Color: Colorless
• Shelf Life: 36 Months
• Packing: as Your Request
• Sample: Free, Available
• Transport Package: Carton
• Specification: 4mg/1ml, 8mg/2ml
• Origin: China
• Production Capacity: 10000000 Ampoules/Month

Product Description

1. Specification:
Injection: 4mg/1ml, 8mg/2ml
2. Strength:
Each mL contains DXMS sodium phosphate equivalent to DXMS
phosphate 4 mg or DXMS3.33 mg.
3. Standard:USP, GMP
4. Packaging: 10ampules/box
5. Shelf life: 36 months



CLINICAL PHARMACOLOGY: 
DXMS sodium phosphate has a rapid myopathyonset but short duration of action 
when compared with less soluble preparations. Because of this, it is suitable forthe treatment of 
acute disorders responsive to adrenocortical steroid therapy. 
Naturally occurring glucocorticoids , which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. 
Their synthetic analogs, including dexamethasone, are primarily used for their potent 
anti-inflammatory effects in disorders of many organ systems. 
Glucocorticoids cause profound and varied meta bolic effects. In addition, they modify the 
body's immune responses to diverse stimuli. 


INDICATIONS:
DXMS can be used for all forms of general and local glucocorticoid injection therapy 
and all acute conditions in which intravenous glucocorticoids may be life-saving.

DOSAGE AND ADMINISTRATION: 
DXMS sodium phosphate injection, 4 mg/mL- For intravenous, intramuscular, 
intra-articular, intralesional, and soft tissue injection. 
DXMS sodium phosphate injection can be given directly from the vial, or it can be 
added to Sodium Chloride Injection or Dextrose Injection and administered by intravenous drip.
Solutions used for intravenous administration or further dilution of this product should be 
preservative free when used in the neonate, especially the premature infant. 
When it is mixed with an infusion solution, sterile precautions should be observed. 
Since infusion solutions generally do not contain preservatives, mixtures should be used within 24hours. 

Packaging and storage- 
Preserve in single-dose or multiple-dose containers, 
preferably of Type I glass, protected from light.
Protect from freezing. Sensitive to heat. Do not autoclave. 
Protect from light. Store container in carton until contents have been used. 
Do not use if precipitate is present.